Nanoliposomal Irinotecan Shows Metastatic Pancreatic Cancer Efficacy

Nanoliposomal irinotecan shows efficacy in patients with gemcitabine-refractory metastatic pancreatic cancer...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.